Risk Paradigm Group’s Bristol-Myers Squibb BMY Stock Holding History

Risk Paradigm Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-500	Closed	-$31.6K	–	107
2018 Q1	$31.6K	Hold	500	–	–	0.04%	163
2017 Q4	$30.6K	Hold	500	–	–	0.03%	188
2017 Q3	$31.9K	Hold	500	–	–	0.04%	170
2017 Q2	$27.9K	Sell	500 -190	-28%	-$10.3K	0.03%	175
2017 Q1	$37.5K	Buy	690 +200	+41%	+$11K	0.04%	166
2016 Q4	$28.6K	Buy	490 +300	+158%	+$16.4K	0.03%	185
2016 Q3	$10.2K	Hold	190	–	–	0.01%	257
2016 Q2	$14K	Hold	190	–	–	0.02%	209
2016 Q1	$12.1K	Hold	190	–	–	0.02%	204
2015 Q4	$13.1K	Hold	190	–	–	0.02%	206
2015 Q3	$11.2K	Hold	190	–	–	0.02%	204
2015 Q2	$12.6K	Hold	190	–	–	0.01%	191
2015 Q1	$12.3K	Buy	+190	New	+$11.9K	0.01%	203

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Risk Paradigm Group's BMY Position: Q2 2018 in Review

Risk Paradigm Group sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 500 shares — an estimated $31.6K sold.

Risk Paradigm Group first reported a position in BMY in Q1 2015 and held it in 13 quarters. The position peaked at $37.5K in Q1 2017. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Risk Paradigm Group reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
Risk Paradigm Group sold 500 Bristol-Myers Squibb shares in Q2 2018, an estimated $31.6K.
Risk Paradigm Group first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 13 quarters.
Risk Paradigm Group's Bristol-Myers Squibb position peaked at $37.5K in Q1 2017.
1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Risk Paradigm Group's 13F filing for Q2 2018, filed 10 Aug 2018.